The Spectrum of African Kaposi's Sarcoma: Is it Consequential upon Diverse Immunological Responses?

References

• Armes J. A review of Kaposi's Sarcoma. Adv Cancer Res 1989; 53: 73–87
   PubMed Web of Science ®Google Scholar
• Penn I. Kaposi's Sarcoma in organ transplant recipients. Transplantation 1979; 27: 8–11
   PubMed Web of Science ®Google Scholar
• Shell A GR. Cancer in organ transplant recipients: part of an induced immune deficiency syndrome. BMJ 1984; 288: 659–661
   PubMedGoogle Scholar
• Gange RW, Wilson-Jones E. Kaposi's Sarcoma and immunosuppressive therapy: an appraisal. Clin Exp Dermatol 1978; 3: 135–145
   PubMed Web of Science ®Google Scholar
• Taylor JF, Templeton AC, Vogel CL, Ziegler JL, Kyalwazi SK. Kaposi's Sarcoma in Uganda: a clinico-pathological study. Int J Cancer 1971; 8: 122–135
   PubMed Web of Science ®Google Scholar
• Bayley AC. Aggressive Kaposi's Sarcoma in Zambia, 1983. Lancet 1984; 1: 1318–1320
   PubMed Web of Science ®Google Scholar
• Bayley AC, Cheinsong-Popov R, Dalgleish AC. HTLV-III serology distinguishes atypical and endemic Kaposi's Sarcoma in Africa. Lancet 1985; 1: 359–361
   PubMed Web of Science ®Google Scholar
• Bayley AC. Occurrence, clinical behaviour and management of Kaposi's Sarcoma in Zambia. Cancer Surv 1991; 10: 53–71
   PubMedGoogle Scholar
• Bayley AC. Atypical Kaposi's Sarcoma in Africa. Kaposi's Sarcoma: a text and atlas, GJ Gotlieb, AB Ackerman. Lea & Febiger, Philadelphia 1988; 151–170
   Google Scholar
• Matondo P. Clinical classification of African Kaposi's Sarcoma: time for reappraissal. Int J Dermatol 1995; 34: 166–167
   PubMed Web of Science ®Google Scholar
• Desmond-Hellman SD, Mbinde EK, Kizito A, Hellman N, Ziegler JL. The value of a clinical definition for epidemic KS in predicting HIV seropositivity in Africa. J Acquir Immune Defic Syndr 1991; 4: 647–651
   PubMed Web of Science ®Google Scholar
• Matondo P. Kaposi's Sarcoma epidemiology. Lancet 1992; 339: 93
   PubMed Web of Science ®Google Scholar
• Chow JW, Lucas SB. Endemic and atypical Kaposi's sarcoma in Africa-histopathological aspects. Clin Exp Dermatol 1990; 14: 253–259
   Google Scholar
• Bhana D, Templeton AC, Master SP, Kyalwazi SK. Kuposi's Sarcoma of lymph nodes. Br J Cancer 1970; 24: 464–470
   PubMed Web of Science ®Google Scholar
• Costa J, Rabson AS. Generalised Kaposi's Sarcoma is not a neoplasm. Lancet 1983; 1: 58
   PubMed Web of Science ®Google Scholar
• Brooks JJ. Kaposi's Sarcoma: a reversible hyperplasia. Lancet 1986; 2: 1309–1311
   PubMed Web of Science ®Google Scholar
• Kaaya EE, Parravicini C, Sundelin B, et al. Spindle cell ploidy and proliferation in endemic and epidemic African Kaposi's sarcoma. Eur J Cancer 1992; 28A: 1890–1894
   PubMed Web of Science ®Google Scholar
• Lunardi-Iskandar Y, Bryant JL, Zeman RA, Lam VH, Samaniego F, Besnier JM, Hermans P, Thierry AR, Gill P, Gallo RC. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 1995; 375: 63–68
   Web of Science ®Google Scholar
• Reynolds WA, Winkelmann RK, Soule EH. Kaposi's Sarcoma: a clinico-pathologic study with particular reference to its relationship to the reticulo-endethelial system. Medicine 1965; 44: 419–443
   PubMed Web of Science ®Google Scholar
• Hutt M SR. The epidemiology of Kaposi's Sarcoma. Antibiotics Chemother 1981; 29: 3–8, Karger, Basel
   PubMedGoogle Scholar
• Friedman-Kien AE, Saltzman BR. Clinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi's Sarcoma. J Am Acad Dermatol 1990; 22: 237–250
   Web of Science ®Google Scholar
• Matondo P, Sivapalan S. Sexually transmissible agent and African Kaposi's Sarcoma. Int J STD AIDS 1996; 7: 4–6
   PubMed Web of Science ®Google Scholar
• Zeigler JL. Endemic Kaposi's sarcoma in Africa and local volcanic soil. Lancet 1993; 342: 1348–1351
   PubMed Web of Science ®Google Scholar
• Montesu MA, De Marco R, Cottoni F. Soll silicates and Kaposi's Sarcoma in Sardinia. Lancet 1995; 346: 1436–1437
   PubMed Web of Science ®Google Scholar
• Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi's Sarcoma among patients with AIDS: a sexually transmitted infection?. Lancet 1990; 335: 123–128
   PubMed Web of Science ®Google Scholar
• Chang Y, Cesarman E, Pessin MS, et al. Identification of herpes virus-like DNA sequences in AIDS-associated Kaposi's Sarcoma. Science 1994; 266: 1865–1869
   PubMed Web of Science ®Google Scholar
• Hyang YQ, Li JJ, Kaplan MH, et al. Human herpes-like nucleic acid in various forms of Kaposi's Sarcoma. Lancet 1995; 345: 759–761
   PubMed Web of Science ®Google Scholar
• Dupin N, Grandadam M, Calvez V, et al. Herpes-like DNA sequences inpatients with Mediterranean Kaposi's Sarcoma. Lancet 1995; 345: 761–762
   PubMed Web of Science ®Google Scholar
• Boshoff C, Whittby D, Hatziioannou T, Fisher C, van der Walt J, Hatzakis A, Weiss R, Schultz T. Kaposi's sarcoma associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet 1995; 345: 1043–1044
   PubMed Web of Science ®Google Scholar
• Giraldo G, Beth E, Couer P, Vogel CL, Dhru DS. Kaposi's Sarcoma: new model in the search for viruses associated with human malignancies. J Natl Cancer Inst 1972; 49: 1495–1507
   PubMed Web of Science ®Google Scholar
• Giraldo G, Beth E, Kourlisky FM, Henle W, Henle G, Mike V, Huraux JM, Andersen HK, Gharbi MR, Kyalwazi SK, Puissant A. Antibody patterns to herpes virus in Kaposi's sarcoma: serological association of European Kaposi's sarcoma with cytomegalovirus. Int J Cancer 1975; 15: 839–848
   PubMed Web of Science ®Google Scholar
• Moore P, Kingsley LA, Holmberg SD, Spira T, Gupta P, Hoover DR, Parry JP, Conley LJ, Jaffe HW, Chang Y. Kaposi's sarcoma-associated herpes virus infection prior to onset of Kaposi's sarcoma. AIDS 1996; 10: 175–80
   PubMed Web of Science ®Google Scholar
• Auerbach R, Sidky YA. Nature of the stimulus leading tolymphocyte-induced angiogenesis. J Immunol 1979; 123: 751–754
   PubMed Web of Science ®Google Scholar
• Levy JA, Ziegler JL. Acquired Immunodeficiency Syndrome is an opportunistic infection and Kaposi's Sarcoma results from secondary immune stimulation. Lancet 1983; 2: 78–80
   PubMed Web of Science ®Google Scholar
• Naidu YM, Rosen EM, Zitnick R, Goldberg I, Mark M, Naujokas M, Polverni PJ, Nickoloff F. Role of scatter factor in the pathogenesis of AIDS-related Kaposi's sarcoma. Proc Natl Acad Sci 1994; 91: 5281–5285
   PubMed Web of Science ®Google Scholar
• Taylor JF, Templeton AC, Kyalwazi SK, Lubenga A. Kaposi's Sarcoma in pregnancy: two case reports. Br J Surg 1971; 58: 577–579
   PubMed Web of Science ®Google Scholar
• Templeton AC. Studies in Kaposi's Sarcoma. Postmortem findings and disease patterns in women. Cancer 1972; 30: 855–867
   Web of Science ®Google Scholar
• Ziegler JL, Katongole-Mbidde E, Wabinga H, Dollman CM. Absence of sex-hormone receptors in Kaposi's Sarcoma. Lancet 1995; 345: 925
   PubMed Web of Science ®Google Scholar
• Qunibi WY, Barri Y, Alfurayh O, et al. Kaposi's Sarcoma in renal transplant recipients: a report on 26 cases from a single institution. Transpl Proc 1993; 25: 1402–1405
   PubMedGoogle Scholar
• Master SP, Taylor JF, Kyalwazi SK, Ziegler JL. Immunological studies in Kaposi's Sarcoma in Uganda. Br Med J 1971; 1: 600–602
   PubMedGoogle Scholar
• Taylor JF, Ziegler JL. Delayed cutaneous hypersensitivity reactions in patients with Kaposi's Sarcoma. Br J Cancer 1974; 30: 312–318
   PubMed Web of Science ®Google Scholar
• Kestens L, Meibya M, Biggar RJ, et al. Endemic African Kaposi's Sarcoma is not associated with immunodeficiency. Int J Cancer 1985; 36: 49–54
   PubMed Web of Science ®Google Scholar
• Taylor JF, Iversen OH, Bjerknes R. Growth kinetics of Kaposi's Sarcoma. Br J Cancer 1977; 35: 470–478
   PubMed Web of Science ®Google Scholar
• Nakamura S, Salahuddin SZ, Biberfield P, et al. Kaposi's Sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4 +cells. Science 1988; 242: 426–430
   PubMed Web of Science ®Google Scholar
• Nair BC, De Vico AL, Nakamura S, et al. Identification of a major growth factor AIDS-Kaposi's Sarcoma cells as onco-statin M. Science 1992; 255: 1430–1432
   PubMed Web of Science ®Google Scholar
• Miles SA, Martinez-Maza O, Rezai A, Copeland TD, Chen Y, Patel A, O'Neil T, Oroszlan S, Gallo RC, Samgadharan HG. Oncostatin M as apotent mitogen for AIDS-Kaposi's Sarcoma-derived cells. Science 1992; 255: 1432–1434
   PubMed Web of Science ®Google Scholar
• Barillari G, Bounaguro L, Fiorelli V, Hoffman J, Michaels F, Gallo RC, Ensoli B. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis. J Immunol 1992; 149: 3727–3734
   PubMed Web of Science ®Google Scholar
• Ensoli B, Barillari G, Gallo RC. Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma. Immunol Rev 1992; 127: 147–155
   PubMed Web of Science ®Google Scholar
• Modlin RL. Th1-Th2 paradigm: insights from leprosy. J Invest Dermatol 1994; 102: 828–831
   PubMed Web of Science ®Google Scholar
• Bentwich Z, Kalinkovich A, Weisman Z. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today 1995; 16: 187–191
   PubMedGoogle Scholar
• Clerici M, Berzofsky JA. Cellular immunity and cytokines in HIV infection. AIDS 1994; 8(Suppl. 1)S175–S182
   Google Scholar